# Zack Abbott

> Zack Abbott is the co-founder and CEO of ZBiotics and inventor of its underlying technology. A Berkeley graduate who also studied classical art and archaeology, he earned his doctorate at the University of Michigan in 2015 and started ZBiotics in 2016. His public accounts cover an early year sleeping near his lab bench, a partnership with Stephen Lamb, candid labeling of genetic engineering and the continuing work of learning to lead a company.

- **Role:** Co-founder and CEO at ZBiotics
- **Organizations:** ZBiotics, Biorasi, University of Michigan, University of California, Davis
- **Education:** Bachelor's degree; molecular and cell biology (immunology) and classical art and archaeology, University of California, Berkeley, PhD in Microbiology and Immunology, University of Michigan
- **Known for:** Invented the foundational technology used by ZBiotics., Co-founded a company that moved from a 2017 laboratory prototype to a 2019 commercial launch., Led ZBiotics through its $12 million Series A announced in August 2024.

## Career timeline

- **2006** — Started work at an analytical chemistry lab in Berkeley.
- **Before 2009** — Worked in a research laboratory at UC Davis before doctoral study.
- **2009–2015** — Studied bacterial genetics under Michele Swanson at the University of Michigan.
- **2015** — Completed his doctorate and subsequently worked at Biorasi.
- **2016** — Started ZBiotics and rented laboratory space in Berkeley.
- **2017-04** — Developed the prototype underlying the first ZBiotics product.
- **2017-05** — Partnered with co-founder Stephen Lamb.
- **2018** — ZBiotics joined Y Combinator's Winter 2018 batch.
- **2019-08** — ZBiotics commercially launched its first product.
- **2024-08** — ZBiotics announced a $12 million Series A led by Spring Tide Capital.
- **2026-08** — In an Ocampo Capital interview, described a team of 45 and ongoing expansion into physical retail.

## Achievements

- Invented the foundational technology used by ZBiotics.
- Co-founded a company that moved from a 2017 laboratory prototype to a 2019 commercial launch.
- Led ZBiotics through its $12 million Series A announced in August 2024.

## Latest updates

- **2026-08** — Discussed founder delegation, physical retail expansion and a 45-person team in an August 18 interview with Karl Bracken of Ocampo Capital.
- **2026-05** — ZBiotics published a detailed founding account on May 13, including the 2017 prototype and early manufacturing and distribution work.

## Links

- Website: https://zbiotics.com/
- LinkedIn: https://www.linkedin.com/in/zaabbott/

---

Profile page: https://yespress.io/zack-abbott
Published by YesPress — https://yespress.io
Last updated: 2026-10-25